Award recordCONTRACT

PROGENICS PHARMACEUTICALS INC

PIID 36C26122N0385· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2022· $4,463,782 net obligations· UEI YLYKVRPCTCR3· MA

Description

PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01 OPTION YEAR 4

Base award description: PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01

First action · last action
2022-03-30 · 2025-10-01
Transactions
9
First transaction's obligation
$702,714
Base + all options value (sum of deltas)
$9,325,290
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79719D0170
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 9 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$4,463,782$0Base award · 2022-03-30 · this action $702,714 · running total $702,714Modification P00001 · 2022-10-01 · this action $1,054,071 · running total $1,756,785Modification P00003 · 2023-10-01 · this action $1,082,616 · running total $2,839,401Modification P00002 · 2024-01-12 · this action -$414,201 · running total $2,425,200Modification P00004 · 2024-06-10 · this action -$235,712 · running total $2,189,488Modification P00005 · 2024-10-01 · this action $1,082,616 · running total $3,272,104Modification P00006 · 2025-03-07 · this action $400 · running total $3,272,504Modification P00008 · 2025-09-24 · this action $108,262 · running total $3,380,766Modification P00007 · 2025-10-01 · this action $1,083,016 · running total $4,463,782
  • Base2022-03-30+$702,714= $702,714
  • Mod P000012022-10-01+$1,054,071= $1,756,785
  • Mod P000032023-10-01+$1,082,616= $2,839,401
  • Mod P000022024-01-12-$414,201= $2,425,200
  • Mod P000042024-06-10-$235,712= $2,189,488
  • Mod P000052024-10-01+$1,082,616= $3,272,104
  • Mod P000062025-03-07+$400= $3,272,504
  • Mod P000082025-09-24+$108,262= $3,380,766
  • Mod P000072025-10-01+$1,083,016= $4,463,782
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-03-30+$702,714$702,714PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01
Mod P00001· EXERCISE AN OPTION2022-10-01+$1,054,071$1,756,785PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01
Mod P00003· EXERCISE AN OPTION2023-10-01+$1,082,616$2,839,401PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01
Mod P00002· FUNDING ONLY ACTION2024-01-12−$414,201$2,425,200PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01
Mod P00004· FUNDING ONLY ACTION2024-06-10−$235,712$2,189,488PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01
Mod P00005· EXERCISE AN OPTION2024-10-01+$1,082,616$3,272,104PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01
Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-03-07+$400$3,272,504PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01
Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-09-24+$108,262$3,380,766PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01
Mod P00007· EXERCISE AN OPTION2025-10-01+$1,083,016$4,463,782PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01 OPTION YEAR 4

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI YLYKVRPCTCR3)

AwardOffice · PSC / listingNet obligationsFY
36C24626N0890246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$1,212,530FY2026
36C24626A0027246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26226F0313262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$180,436FY2026
36C25026N0655250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$721,744FY2026
36C26026F0298260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$469,134FY2026
36C25026N0531250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$559,352FY2026

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26122N0385_3600_36F79719D0170_3600 · retrieved 2026-09-26.